FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $17,141,310 | 5.32% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $13,766,268 | 3.60% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $7,289,786 | 2.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,329,258 | $6,207,635 | 0.97% |
| Avidity Partners Management LP | 5,700,000 | $26,619,000 | 0.93% |
| Ghost Tree Capital, LLC | 412,699 | $1,927,304 | 0.64% |
| Eagle Health Investments LP | 680,370 | $3,177,328 | 0.59% |
| Perceptive Advisors | 2,751,395 | $12,849,014 | 0.37% |
| Sio Capital Management, LLC | 246,036 | $1,148,988 | 0.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,823,000 | $13,183,410 | 0.28% |
| Orbimed Advisors | 3,122,770 | $14,583,336 | 0.26% |
| Artal Group S.A. | 1,725,000 | $8,056 | 0.25% |
| TPG GP A, LLC | 2,551,794 | $11,916,878 | 0.18% |
| FEDERATED HERMES, INC. | 10,633,789 | $49,766,133 | 0.12% |
| Forefront Analytics, LLC | 20,075 | $93,753 | 0.05% |
| SECTORAL ASSET MANAGEMENT INC | 57,297 | $267,577 | 0.04% |
| UBS OCONNOR LLC | 274,568 | $1,284,978 | 0.04% |
| Sofinnova Investments, Inc. | 117,099 | $546,852 | 0.04% |
| CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 | $14,587,401 | 0.02% |
| Tekla Capital Management LLC | 43,394 | $203,084 | 0.01% |
External links
This page lists FUSION PHARMACEUTICALS INC's shareholders in Q2 2023. To view FUSION PHARMACEUTICALS INC's shareholder history, click here.